Clinical Trial Update: A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of semaglutide injection for type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Hangzhou Jiuyuan Gene Engineering Co. Ltd., | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED